Topical recombinant thrombin at a concentration of 1000 IU/mL reliably shortens in vivo TTH and delivers durable hemostasis in the presence of heparin anticoagulation and clopidogrel platelet inhibition in a rabbit model of vascular bleeding

Annals of Surgical Innovation and Research

Volumn 3, Issue , 2009, Pages

  Hughes, Steven D ^a   Bishop, Paul D ^a   Garcia, Richard ^a   Zhang, Tracy ^a   Alexander, W Allan ^a  

^a ZYMOGENETICS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77954881545     PISSN: None     EISSN: 17501164     Source Type: Journal    
DOI: 10.1186/1750-1164-3-14     Document Type: Article

References (20)

1. Bishop PD, Lewis KB, Schultz J, Walker KM. Comparison of recombinant human thrombin and plasma-derived human alpha-thrombin. Semin Thromb Hemost 2006, 32(Suppl 1):86-97. 10.1055/s-2006-939558, 16673270.
2. Lundblad RL, Bradshaw RA, Gabriel D, Ortel TL, Lawson J, Mann KG. A review of the therapeutic uses of thrombin. Thromb Haemost 2004, 91:851-60.
3. Chapman WC, Singla N, Genyk Y, McNeil JW, Renkens KL, Reynolds TC, Murphy A, Weaver FA. A phase 3, randomized, double-blind comparative study of the efficacy and safety of topical recombinant human thrombin and bovine thrombin in surgical hemostasis. J Am Coll Surg 2007, 205:256-65. 10.1016/j.jamcollsurg.2007.03.020, 17660072.
4. Doria C, Fischer CP, Wood CG, Li PM, Marra S, Hart J. Phase 3, randomized, double-blind study of plasma-derived human thrombin versus bovine thrombin in achieving hemostasis in patients undergoing surgery. Curr Med Res Opin 2008, 24:785-94. 10.1185/030079908X273426, 18241525.
5. Singla NK, Ballard JL, Moneta G, Randleman CD, Renkens KL, Alexander WA. A phase 3b, open-label, single-group immunogenicity and safety study of topical recombinant thrombin in surgical hemostasis. J Am Coll Surg 2009, 209:68-74. 10.1016/j.jamcollsurg.2009.03.016, 19651065.
6. Wolberg AS. Thrombin generation and fibrin clot structure. Blood Rev 2007, 21:131-42. 10.1016/j.blre.2006.11.001, 17208341.
7. Blombäck B, Carlsson K, Hessel B, Liljeborg A, Procyk R, Aslund N. Native fibrin gel networks observed by 3D microscopy, permeation and turbidity. Biochim Biophys Acta 1989, 997:96-110.
8. Blombäck B, Carlsson K, Fatah K, Hessel B, Procyk R. Fibrin in human plasma: gel architectures governed by rate and nature of fibrinogen activation. Thromb Res 1994, 75:521-38. 10.1016/0049-3848(94)90227-5, 7992253.
9. Heffernan JK, Ponce RA, Zuckerman LA, Volpone JP, Visich J, Giste EE, Jenkins N, Boster D, Pederson S, Knitter G, Palmer T, Wills M, Early RJ, Rogge MC. Preclinical safety of recombinant human thrombin. Regul Toxicol Pharmacol 2007, 47:48-58. 10.1016/j.yrtph.2006.07.006, 16971028.
10. Meehan WP, Bolton MT. Recombinant human thrombin: demonstration of efficacy in models of surgical bleeding [abstract P54]. J Surg Res 2004, 121:323.
11. Adams GL, Manson RJ, Hasselblad V, Shaw LK, Lawson JH. Acute in-vivo evaluation of bleeding with Gelfoam™ plus saline and Gelfoam plus human thrombin using a liver square lesion model in swine. J Thromb Thrombolysis 2009, 28:1-5. 10.1007/s11239-008-0249-3, 18629446.
12. IMS Health Incorporated Top 15 global products. IMS Health Incorporated., http://www.imshealth.com/portal/site/imshealth/menuitem.a46c6d4df3db4b3d88f611019418c22a/?vgnextoid=cec0977ccedc0210VgnVCM100000ed152ca2RCRD&cpsextcurrchannel=1
13. Ho PM, Peterson ED, Wang L, Magid DJ, Fihn SD, Larsen GC, Jesse RA, Rumsfeld JS. Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome. JAMA 2008, 299:532-39. 10.1001/jama.299.5.532, 18252883.
14. Weaver FA, Lew W, Granke K, Yonchiro L, Delange B, Alexander WA. A comparison of recombinant thrombin to bovine thrombin as a hemostatic ancillary in patients undergoing peripheral arterial bypass and arteriovenous graft procedures. J Vasc Surg 2008, 47:1266-73. 10.1016/j.jvs.2008.01.034, 18440754.
15. Chandler WL. The thromboelastograph and the thromboelastograph technique. Semin Thromb Hemost 1995, 21(Suppl 4):1-6.
16. ZymoGenetics Inc Prescribing information: RECOTHROM™. 2009, ZymoGenetics Inc., http://www.recothrom.com/prescribing_info/default.aspx
17. Valentin JP, Vieu S, Bertolino F, Fauré P, John GW. Differential involvement of serotonin 2A/C and thromboxane A2/prostanoid receptors in high- vs. low-shear rate arterial thrombosis in rabbits. J Pharmacol Exp Ther 1997, 280:761-69.
18. Bishop P, Lawson J. Recombinant biologics for treatment of bleeding disorders. Nat Rev Drug Discov 2004, 3:684-94. 10.1038/nrd1443, 15286735.
19. Greilich PE, Brouse CF, Beckham J, Jessen ME, Martin EJ, Carr ME. Reductions in platelet contractile force correlate with duration of cardiopulmonary bypass and blood loss in patients undergoing cardiac surgery. Thromb Res 2002, 105:523-29. 10.1016/S0049-3848(02)00061-0, 12091054.
20. Taketomi T, Szlam F, Vinten-Johansen J, Levy JH, Tanaka KA. Thrombin-activated thrombelastography for evaluation of thrombin interaction with thrombin inhibitors. Blood Coagul Fibrinolysis 2007, 18:761-67. 10.1097/MBC.0b013e3282f102c6, 17982317.